These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21420988)

  • 1. Psychopharmacological treatment of schizophrenia: what do we have, and what could we get?
    Ellenbroek BA
    Neuropharmacology; 2012 Mar; 62(3):1371-80. PubMed ID: 21420988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
    Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
    Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
    Miyamoto S; Duncan GE; Marx CE; Lieberman JA
    Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic approaches to cognitive enhancement in schizophrenia.
    Burdick KE; Gopin CB; Malhotra AK
    Harv Rev Psychiatry; 2011; 19(3):102-8. PubMed ID: 21631157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia treatment. Critical review on the drugs and mechanisms of action of antipsychotics.
    Tajima K; Fernández H; López-Ibor JL; Carrasco JL; Díaz-Marsá M
    Actas Esp Psiquiatr; 2009; 37(6):330-42. PubMed ID: 20066585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.
    Rao NP; Remington G
    Expert Opin Investig Drugs; 2013 Jul; 22(7):881-94. PubMed ID: 23639138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic approaches in the development of novel antipsychotics.
    Jones CA; McCreary AC
    Neuropharmacology; 2008 Nov; 55(6):1056-65. PubMed ID: 18621404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs in development for the treatment of schizophrenia.
    Emsley R
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1103-18. PubMed ID: 19589093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action.
    Wong EH; Tarazi FI; Shahid M
    Pharmacol Ther; 2010 May; 126(2):173-85. PubMed ID: 20171983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of biomarkers in the discovery of novel anti-schizophrenia drugs.
    Mikkelsen JD; Thomsen MS; Hansen HH; Lichota J
    Drug Discov Today; 2010 Feb; 15(3-4):137-41. PubMed ID: 20036755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems in evaluating new antipsychotic drugs].
    Fleischhacker WW
    Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the cholinergic system in the pathology and treatment of schizophrenia.
    Scarr E; Dean B
    Expert Rev Neurother; 2009 Jan; 9(1):73-86. PubMed ID: 19102670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiological background for the development of new drugs in schizophrenia.
    López-Muñoz F; Álamo C
    Clin Neuropharmacol; 2011; 34(3):111-26. PubMed ID: 21586917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional versus novel antipsychotics: changing concepts and clinical implications.
    Remington G; Chong SA
    J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia and antipsychotic drugs.
    Nurnberg HG; Levine PE
    Compr Ther; 1986 Oct; 12(10):42-52. PubMed ID: 2877767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
    Gosselin O; Ribeyre JM; Kahn JP
    Encephale; 1997 Sep; 23 Spec No 4():2-6. PubMed ID: 9417400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules.
    Mouri A; Nagai T; Ibi D; Yamada K
    Neurobiol Dis; 2013 May; 53():61-74. PubMed ID: 23142533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.